Compare KWR & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KWR | ATEC |
|---|---|---|
| Founded | 1918 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 1994 | 2006 |
| Metric | KWR | ATEC |
|---|---|---|
| Price | $119.92 | $12.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $152.50 | $22.00 |
| AVG Volume (30 Days) | 158.7K | ★ 2.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,888,634,000.00 | $101,739,000.00 |
| Revenue This Year | $5.05 | $17.79 |
| Revenue Next Year | $4.03 | $16.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.66 | N/A |
| 52 Week Low | $95.91 | $8.82 |
| 52 Week High | $183.01 | $23.29 |
| Indicator | KWR | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 23.40 | 40.37 |
| Support Level | $111.56 | $12.03 |
| Resistance Level | $126.57 | $12.97 |
| Average True Range (ATR) | 5.23 | 0.52 |
| MACD | -2.21 | 0.12 |
| Stochastic Oscillator | 10.03 | 29.76 |
Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.